PUBLIC EVIDENCE LAB

Inspect Timory's source links, recurrence rules and explicit unknowns.

Get the weekly brief →

Name a market. We will look for recurring, source-linked evidence—not tell you what to build.

LAST COLLECTION <1h ago22972 SIGNALS10 FEEDS1824 PAYMENT-EVIDENCE SIGNALS
#DossierEvidence levelRecurrenceRecency
161 Opportunity dossier O-12459 Recurring need documented in 8 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed8 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 162 Opportunity dossier O-11817 Recurring need documented in 3 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated3 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 163 Opportunity dossier O-6117 Recurring need documented in 5 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed5 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 164 Claude Code Approval Fatigue Mitigation A Claude Code permissions tool with granular rules for bash and tool calls, session-level allowlists and batch approvals, to cut the interruption of confirming every run. Evidence levelPayment-backed12 items · 3 sources · 1 payment 12-week activity Recency 2026-10-30 165 Opportunity dossier O-8808 Recurring need documented in 4 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated4 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 166 Opportunity dossier O-3352 Recurring need documented in 7 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed7 items · 2 sources · 1 payment 12-week activity Recency 2026-10-30 167 Opportunity dossier O-2691 Recurring need documented in 7 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed7 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 168 Opportunity dossier O-10293 Recurring need documented in 9 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed9 items · 1 source · 2 payment 12-week activity Recency 2026-10-30 169 Opportunity dossier O-2278 Recurring need documented in 11 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated11 items · 1 source · 6 payment 12-week activity Recency Fading · 2026-10-30 170 Opportunity dossier O-1324 Recurring need documented in 12 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated12 items · 2 sources · 1 payment 12-week activity Recency 2026-10-30 171 Opportunity dossier O-6066 Recurring need documented in 6 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed6 items · 1 source · 4 payment 12-week activity Recency 2026-10-30 172 Opportunity dossier O-10868 Recurring need documented in 5 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed5 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 173 Opportunity dossier O-8966 Recurring need documented in 8 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated8 items · 2 sources 12-week activity Recency 2026-10-30 174 Opportunity dossier O-10918 Recurring need documented in 2 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal2 items · 1 source · 2 payment 12-week activity Recency 2026-10-30 175 Opportunity dossier O-10534 Recurring need documented in 2 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal2 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 176 Opportunity dossier O-9702 Recurring need documented in 2 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal2 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 177 Opportunity dossier O-9628 Recurring need documented in 2 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal2 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 178 Opportunity dossier O-12425 Recurring need documented in 2 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal2 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 179 Opportunity dossier O-5786 Recurring need documented in 3 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated3 items · 1 source · 2 payment 12-week activity Recency 2026-10-30 180 Opportunity dossier O-8893 Recurring need documented in 5 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated5 items · 1 source 12-week activity Recency 2026-10-30

Public dossiers offer free email unlock for the full evidence chain. Free Market Watch is self-serve: name a niche, preview matching dossiers and save change alerts over Timory's shared corpus.